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Objective: To evaluate the efficacy of intrathecal hyperbaric bupivacaine premixed with dexmeditomidine compared with 
sequential administration in separate syringes on block characteristics, haemodynamic parameters, side effect profile and 
postoperative analgesic requirement.
Trial design: This was a prospective, randomised clinical study
Method: Sixty orthopaedic patients scheduled for elective lower limb surgery under spinal anaesthesia were divided into two 
groups to receive either intrathecal hyperbaric bupivacaine 12.5 mg premixed (Group P) with dexmeditomidine 10 μg (diluted to 
0.5 ml with normal saline) or by sequential administration in separate syringes (Group S).
Outcome: Block characteristics, haemodynamic parameters, side effect profile and postoperative analgesic requirement were 
compared in both groups. 
Results: Time to achieve T10 spinal level was significantly less in group S (4.467  +   0.973  min) compared with group P 
(5.5 + 1.167 min). Similarly, patients in group S achieved Modified Bromage III earlier (6.1 + 1.296 min) than group P (7.5 + 1.333 min), 
p-value 0.0001. 
Conclusion: Dexmeditomidine given sequentially in a separate syringe as adjuvant to intrathecal hyperbaric bupivacaine can 
result in faster onset of both sensory and motor block and prolongs the duration of spinal anaesthesia, minimises clinically 
significant side effects and reduces the postoperative analgesic requirement.
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Introduction
Due to its lower cost, simpler technique and higher patient 
acceptance spinal anaesthesia is fast becoming the procedure of 
choice for lower limb and lower abdominal surgeries. Duration of 
spinal anaesthesia depends on the local anaesthetic used and is 
an important limiting factor of this technique. Many adjuvants 
have been tried with local anaesthetics to increase the duration 
of effect, to provide stable haemodynamics and to minimise 
complications. It is common practice to mix adjuvant drugs with 
hyperbaric local anaesthetic in the same syringe but that can 
alter the density of local anaesthetic solution influencing spread 
of the drug in the cerebrospinal fluid.
Various factors that have been shown to influence the intrathecal 
spread of local anaesthetic are temperature and pH of the drug, 
baricity and patient position after injection.1 Studies have already 
shown that premixing adjuvants with hyperbaric bupivacaine 
might alter its spread in CSF.2 Conversely, administering adjuvants 
sequentially in separate syringes may minimise the change in 
density and pH of both drugs, preventing any alteration in CSF 
spread.
Dexmedetomidine, a highly selective α2-adrenoreceptor 
agonist, has been found to be useful as an intrathecal adjuvant 
to local anaesthetics. It provides stable haemodynamics and 
prolongs analgesic effect.3,4 However, no study was found in the 
literature comparing premixed with sequential administration of 
dexmeditomidine with intrathecal local anaesthetic. Therefore 
the aim of this study was to study the effect of intrathecal 
administration of hyperbaric bupivacaine premixed with 
dexmedetomidine compared with sequential administration in 
separate syringes on block characteristics, haemodynamic 
parameters, side effect profile and postoperative pain.
Materials and methods
This study was conducted in BPS Government Medical College 
(FW) after approval by the Institutional Ethics Committee. Sixty 
orthopaedic patients scheduled for elective lower limb surgery 
under spinal anaesthesia were enrolled in this study. All the 
patients were ASA class 1 and 2, aged between 15 and 60 years 
with no significant comorbidities. Patients with ASA grade higher 
than 2, age less than 15 years or more than 60 years, anticipated 
duration of surgery more than 1 hour and history of allergy to 
dexmeditomidine or bupivacaine were excluded from this study.
Written informed consent was obtained from all patients before 
starting the study. All patients had undergone preanaesthetic 
check-up before surgery. Patients were kept nil per os for six 
hours before surgery. Patients were taken into the preoperative 
room and vitals were recorded including heart rate, ECG, oxygen 
saturation and non-invasive blood pressure. Patients were then 
taken into the operating theatre.
In the operating room, intravenous access was secured with 18G 
intravenous cannula and monitors were attached. All the patients 
were randomly divided into two groups with 30 patients in each 
group using a computer-generated program. Patients in group P 
received intrathecal hyperbaric bupivacaine 12.5  mg premixed 
with dexmeditomidine 10 μg (diluted to a volume of 0.5 ml with 
normal saline). The drugs were mixed together in a single syringe 
just before intrathecal injection. Those in group S received 
intrathecal hyperbaric bupivacaine 12.5  mg followed by 
sequential administration of dexmeditomidine 10  μg (total 
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volume 0.5  ml with normal saline) in a separate syringe 
intrathecally. Spinal anaesthesia was administered using a 25G 
Quincke needle with patients in a sitting position. After spinal 
anaesthesia all patients were made to lie supine to achieve the 
desired sensory level. All patients received intravenous Ringer’s 
lactate solution at the rate of 10 ml/kg/h during the intraoperative 
period.
Haemodynamic parameters, i.e. heart rate, blood pressure and 
oxygen saturation, were recorded every 2 minutes for the first 10 
minutes and every 5  minutes subsequently till completion of 
surgery. An episode of hypotension was defined as systolic blood 
pressure below 90  mmHg or a fall in blood pressure by more 
than 20% of baseline values) and bradycardia as heart rate < 50 
beats/min or even higher, if there were associated clinical signs 
and symptoms. For hypotension, the patient received a rapid 
infusion of crystalloids (200 ml of normal saline or ringer lactate) 
and ephedrine 5 mg intravenously if hypotension persisted. For 
bradycardia, the patient received atropine 0.02  mg/kg 
intravenously.
The progression of spinal block was assessed using pin-prick 
every 1  minute until the maximum level was reached. Surgery 
was started only after sensory level up to T10 or higher was 
achieved. Time to achieve T10 level as well as maximum height of 
block was noted and compared. At the same time a modified 
Bromage scale was used to assess the motor block as: I — no 
block with full flexion possible at knees and feet; II — partial 
block, with patient just able to flex knees with full flexion possible 
at feet; III — almost complete, with patient unable to flex knees 
but flexion of feet possible; and IV — complete block, i.e. inability 
to move legs and feet. Time to achieve Bromage III was recorded.
Postoperatively patients were observed for a period of six hours 
following intrathecal injection in the post-anaesthesia care unit. 
Time of regression of sensory block two dermatomes below the 
maximum block height and that of motor block to Bromage I was 
noted. Also time of demand of first rescue analgesic was also 
noted. All patients received injection of fentanyl 1.5 mcg/kg on 
demand if they complained of pain. Requirement for rescue 
analgesic was assessed in terms of total doses of injections of 
fentanyl given to each group. Any side effects such as nausea, 
vomiting, excessive sedation or respiratory depression during 
the intraoperative period were also noted.
The primary outcome was to study the effect of sequential 
administration of intrathecal dexmeditomidine on characteristics 
of spinal block (onset, maximum height of block and duration) 
compared with when administered premixed in the same 
syringe. A secondary outcome was to compare clinically 
significant side effects noticed among patients in both groups as 
well as postoperative analgesic requirement.
Statistical analysis
Based on similar studies2 in the past, sample size estimation was 
done based on time for two-segment regression of spinal block 
as primary end point. To achieve a level of significance of 0.05 
and a power of 80% a sample size of 30 patients was required per 
group. So, 60 patients in total were considered for this study. 
Data were entered into a Microsoft Excel® spreadsheet and 
analysed using Statistical Package for Social Sciences® version 16 
(SPSS Inc., Chicago, IL, USA). Qualitative data were expressed as 
ratio and proportion and analysed using a chi-square test, while 
quantitative data were analysed with an unpaired t-test. A p-
value < 0.05 was considered statistically significant.
Results
Thirty patients were studied in each group. Patients in both 
groups were comparable in terms of age, sex, height, weight and 
ASA physical status (Table 1). All patients underwent lower limb 
surgery under spinal anaesthesia and duration of surgery was 
comparable in both groups with no statically significant 
difference. There was no incidence of failed spinal block in any 
patient.
More patients in group P achieved a higher level of intrathecal 
block than in group S (Table 2). However, time to achieve T10 
spinal level was significantly less in group S (4.467 ± 0.973 min) 
compared with group P (5.5 ± 1.167 min) (p-value 0.0004) (see 
Table 2). Also, patients in group S achieved maximum sensory 
Table 1: Comparison of demographic variables of patients
Demographic variables Group P (n = 30) Group S (n = 30) p-value
Age (years) 34.68  +  13.13 34.91  +  11.18 0.944
Sex (M:F) 23:7 24:6
Weight (kg) 65.86  +  5.32 66.18  +  4.78 0.807
Height (cm) 163.02  +  8.24 161.92  +  6.458 0.571
ASA Status (I/II) 18/12 19/11
Duration of surgery (minutes) 56.92  +  6.581 58.21  +  5.373 0.409
Table 2: Comparison of sensory and motor characteristics of spinal anaesthesia
Factor Group P (n = 30) Group S (n = 30) p-value
Maximum sensory level achieved T4:T6:T8:T10 3:7:16:4 1:6:14:9
Time to reach T10 sensory level (minutes) 5.5  +  1.167 4.467  +  0.973 0.0004
Time to reach maximum sensory level (minutes) 11.17  +  1.56 10.37  +  1.474 0.0454
Time for two-segment regression of sensory level (minutes) 119  +  17.291 131  +  14.937 0.0056
Time to achieve Modified Bromage III (minutes) 7.5  +  1.333 6.1  +  1.296 0.0001
Time of regression of motor block to Modified Bromage I (minutes) 129.67  +  18.473 145  +  19.783 0.0030
Total no. of doses of injection of fentanyl used (in first 6 hours) 14 11
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block earlier than those in group P (10.37 ± 1.474 min vs. 11.17 ± 
1.56  min, p-value 0.0454). Time for two-segment regression of 
sensory block was significantly longer in group S (131 ± 
14.937  min) than group P (119 ± 17.291  min) (p-value 0.0056). 
Similarly, patients in group S achieved Modified Bromage III 
earlier (6.1 ± 1.296 min) than group P (7.5 ± 1.333 min), p-value 
0.0001 (see Table 2). Time to regression of motor block to 
Modified Bromage I was also significantly more in group S (145 ± 
19.783 min) than in group P (129.67 ± 18.473).
Haemodynamically, there was no significant difference in the 
baseline heart rate and blood pressure between two groups 
(Tables 4, 5 & 6). After spinal injection, though heart rate and 
blood pressure (both systolic and diastolic) decreased in both 
groups, the extent of fall (Figures 1, 2 & 3) was more in group S as 
compared with group P.
Postoperatively, patients in group S required less rescue analgesic 
than group P (11 doses of injection of fentanyl during the first 6 
hours vs. 14 doses) (see Table 2). The incidence of adverse effects 
was also considerably less in group S compared with group P 
(Table 3). In group S only 2 patients reported nausea/vomiting, 1 
had bradycardia (heart rate < 60/minute) and 2 patients had 
hypotension (systolic blood pressure < 90 mm hg or 20% below 
preoperative level) and none reported shivering. In group P, 3 
patients reported nausea/vomiting, 5 had bradycardia and 4 had 
hypotension and one patient reported shivering (see Table 3).
Discussion
Dexmedetomidine is a highly selective alpha-2 adrenoreceptor 
agonist that acts as a central sympatholytic, blocking the release 
of noradrenaline by acting on presynaptic terminals. It has been 
found to be useful in various aspects of anaesthesia and critical 
care due to its sympatholytic, analgesic and sedative properties.5–7 
It is also emerging as an effective adjuvant with local anaesthetics 
for both regional8 and spinal anaesthesia.
Various studies have been done to assess the effect of adding 
dexmedetomidine to intrathecal local anesthetic.9–11 
Dexmedetomidine has been found to increase the duration of 
analgesia with minimal side effects. Though the mechanism of 
this effect is not clear, it is proposed to act by binding to 
presynaptic C fibres, thus depressing the release of 
neurotransmitters, and by hyperpolarisation of postsynaptic 
dorsal horn neurons.9, 10 It is also shown to reduce the incidence 
of shivering in the postoperative period and the post-anaesthetic 
analgesic requirement. Similarly, studies have been done to 
determine the optimal intrathecal dose of dexmeditomidine.12–14 
These studies have shown that there is a dose-dependent 
potentiation of effect with dexmeditomidine without any 
increase in incidence of side effects and an intrathecal dose of 10 
mcg improves the onset of block, prolongs duration and thus 
reduces postoperative analgesic requirement.
However, adding an adjuvant to hyperbaric local anaesthetic 
might alter its density and thus may influence its spread in the 
intrathecal space. Various studies have been done in the past to 
determine the density of cerebrospinal fluid.15,16 It was found to 
be 1.00059 ± 0.00020 in men and non-pregnant females.16 The 
effect of adding adjuvants to intrathecal local anaesthetics was 
studied by Imbelloni et al.,17 who found that addition of adjuvants 
may alter density of the solution at 37°C, yet the resultant 
solution remained hyperbaric.
Figure 1: Comparison of mean heart rate in the two groups.
Figure 2: Comparison of systolic blood pressure in the two groups.
Figure 3: Comparison of diastolic blood pressure in the two groups.
Table 3: Comparison of adverse side effects noted in the two groups
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In this study we compared the effect of adding dexmedetomidine 
to hyperbaric bupivacaine for intrathecal block as a premixed 
preparation and when both these drugs are used sequentially in 
separate syringes. We found that patients in group S achieved 
both sensory and motor block earlier than those in group P. 
Though there was no statistically significant difference in the 
maximum sensory level achieved in both groups, patients in 
group P tended to achieve a higher level of sensory block. Also, 
time for two-segment regression of sensory blockage and for 
motor blockage to regress to Modified Bromage I was significantly 
greater in group S as compared with group P.
Similarly a study by Desai et al.18 showed that mixing intrathecal 
opioids with hyperbaric bupivacaine for intrathecal 
administration might result in higher opioid requirement in the 
postoperative period. They postulated that both hyperbaric 
bupivacaine and opioids (morphine and fentanyl) could produce 
maximum effect at their original densities and that mixing them 
alters their densities, affecting spread in the CSF and thus 
reducing the duration of analgesia. Therefore sequential 
administration helps to maintain the physical properties of both 
drugs, resulting in optimal effect.
Table 4: Comparison of heart rate in the two groups
Time (mins) Group P (n = 30) Group S (n = 30) p-value
0 81.3  +  11.32 82.97  +  10.43 0.556
2 82.37  +  11.86 81.27 + 10.04 0.699
4 77.06 + 12.55 83.6 + 10.76 0.0345
6 75.8 + 9.21 81.8 + 11.16 0.0268
8 70.27 + 9.303 76.2 + 11.83 0.0350
10 70.4 + 11.21 79.2 + 12.49 0.0057
20 69.4 + 7.85 76.4 + 10.78 0.0056
30 73.06 + 8.08 78.47 + 10.77 0.0321
40 74.6 + 8.05 78.53 + 9.88 0.0964
50 74.53 + 7.50 78 + 9.31 0.1176
60 73.4 + 5.36 77.6 + 8.39 0.0245
Table 5: Comparison of systolic blood pressure in the two groups
Time (mins) Group P (n = 30) Group S (n = 30) p-value
0 121.73 + 12.77 118.26 + 11.67 0.2771
2 118.53 + 9.54 117.27 + 9.21 0.6028
4 114.87 + 7.14 116.53 + 9.38 0.4418
6 114.2 + 9.22 118.8 + 11.24 0.0886
8 114.8 + 7.69 117.73 + 12.02 0.265
10 111 + 7.75 113.07 + 9.724 0.3664
20 107.88 + 8.376 113.07 + 8.97 0.0131
30 108 + 8.069 110.4 + 9.792 0.3023
40 106.93 + 7.55 109 + 8.63 0.3276
50 108.6 + 7.069 110.87 + 11.69 0.3673
60 105.53 + 7.943 110.27 + 8.43 0.0291
Table 6: Comparison of diastolic blood pressure in the two groups
Time (mins) Group P (n = 30) Group S (n = 30) p-value
0 78.7 + 9.77 78.53 + 10.22 0.948
2 77.47 + 10.22 78 + 9.307 0.833
4 76.27 + 9.08 77.67 + 9.81 0.568
6 75.07 + 7.216 77.6 + 8.394 0.215
8 72.2 + 8.7 76.6 + 8.601 0.0536
10 70.73 + 9.34 74.2 + 8.49 0.138
20 67.67 + 6.99 74.6 + 8.156 0.0008
30 70.87 + 8.45 71.8 + 8.98 0.679
40 68.73 + 7.99 74.07 + 10.64 0.032
50 69.47 + 8.303 72.6 + 9.16 0.1704
60 69.4 + 7.89 69.93 + 6.89 0.7816
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Though in both groups the patients remained calm and 
cooperative, clinically significant sedation was not seen in any 
patient. Many studies8–10 have shown that dexmeditomidine, 
when used as an intrathecal adjuvant, decreases postoperative 
analgesic requirement. This analgesic sparing effect was more 
pronounced in group S as compared with group P as requirement 
for rescue analgesic was significantly less in group S during the 
first six hours postoperatively.
Adding dexmeditomidine to spinal local anaesthetic has been 
shown to cause bradycardia and hypotension due to the 
sympatholytic effect of alpha 2 adrenoreceptor agonists.19 In a 
study Al-Mustafa et al. showed that addition of dexmeditomidine 
to bupivacaine leads to a dose-dependent yet insignificant 
decrease in mean arterial pressure.1 No significant hypotension 
or bradycardia was noted in our study. The reason for this may be 
the lower level of spinal block achieved for this study and small 
dose of intrathecal dexmeditomidine used. Similar findings were 
reported by Mahendru et al.20 who showed alpha 2 
adrenoreceptor agonists did not have much effect as near 
maximal sympatholysis was already achieved by local 
anaesthetics.
Though this study improves our understanding of using 
dexmedetomidine as an intrathecal adjuvant, it had certain 
limitations. First, the patients included in this study were all 
healthy individuals with no significant comorbidities. Thus the 
effect of intrathecal dexmeditomidine on patients with 
significant cardiovascular problems remains to be studied. 
Second, only patients undergoing elective lower limb surgery of 
less than one-hour duration were considered for this study. 
Therefore the amount of intrathecal block required for surgery 
was never high enough to produce clinically significant 
bradycardia or hypotension. So, the relative potentiation of this 
side effect by dexmedetomidine given sequentially and in 
premixed form remains to be seen. Hence further studies are 
required with a higher number of patients, and those with 
cardiovascular compromise, or undergoing more complex lower 
limb or lower abdominal procedures, to establish the benefits of 
one technique over another.
Conclusion
In conclusion, dexmeditomidine given sequentially in a separate 
syringe as adjuvant to intrathecal hyperbaric bupivacaine can 
result in faster onset of both sensory and motor block and 
prolongs the duration of spinal anaesthesia, minimises clinically 
significant side effects and reduces the postoperative analgesic 
requirement as compared with when used in premixed form in 
the same syringe in patients undergoing elective lower limb 
surgery.
Notes
(1)  Mixing adjuvant drugs with hyperbaric local anaesthetic 
in the same syringe may alter the density of local 
anaesthetic, influencing spread of the drug in the 
cerebrospinal fluid.
(2)  Administering adjuvants sequentially in separate 
syringes may minimise the changes in densities and pH 
preventing any alteration in CSF spread.
